A New Look at Catalyst Pharmaceuticals Inc (CPRX) Stock’s Hidden Strategies

Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]

Catalyst Pharmaceuticals Inc (CPRX) Stock is the one stock you should own forever

Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]

Invest in Catalyst Pharmaceuticals Inc (CPRX) Stock with the prospect of future returns

Oppenheimer raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “an Outperform”. The rating was released on December 21, 2023, according to finviz. We previously noted in another research note published on August 24, 2022 by ROTH Capital that downgraded the stock from a Buy to a Neutral with a price target […]

What does the future hold for Catalyst Pharmaceuticals Inc (CPRX) Stock?

Oppenheimer raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “an Outperform”. The rating was released on December 21, 2023, according to finviz. We previously noted in another research note published on August 24, 2022 by ROTH Capital that downgraded the stock from a Buy to a Neutral with a price target […]

Top-line Growth is Likely to Be Driven by Catalyst Pharmaceuticals Inc (CPRX) Stock

Oppenheimer raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “an Outperform”. The rating was released on December 21, 2023, according to finviz. We previously noted in another research note published on August 24, 2022 by ROTH Capital that downgraded the stock from a Buy to a Neutral with a price target […]

A Real Picture of Catalyst Pharmaceuticals Inc (CPRX) Stock: The Fundamentals

Oppenheimer raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “an Outperform”. The rating was released on December 21, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price […]

Catalyst Pharmaceuticals Inc (CPRX) Stock: Amazing technical data that you never knew existed

Oppenheimer raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “an Outperform”. The rating was released on December 21, 2023, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -6.91% within the last five trades and -5.63% within the last 30 […]